Ozempic on Wall Street’s list for 2027 Medicare drug negotiations

Now that the US government has negotiated prices for some Medicare drugs that will take effect in 2026, Wall Street analysts are betting on a 2027 list that will include Novo Nordisk, which makes Ozempic for diabetes and has limited impact on big pharma.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM